Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Burkitt Lymphoma × pomalidomide × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 6 Paraproteinemias 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Lymphoma, B-Cell 1 Hematologic Diseases 1 Corneal Diseases 1 Burkitt Lymphoma 1 Blood Protein Disorders 1

Interventions

blinatumomab 2 Immunotherapy, Adoptive 2 pomalidomide 1 Specimen Handling 1 Interleukin 1 Receptor Antagonist Protein 1 Inotuzumab Ozogamicin 1 Biological Products 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07532525 2026-04-16

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

University of Michigan Rogel Cancer Center

Phase 1 Not yet recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡